Gruis N - Search Results

1

Geographical variation in the penetrance of CDKN2A mutations for melanoma.

Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA; Melanoma Genetics Consortium. Bishop DT, et al. Among authors: gruis n. J Natl Cancer Inst. 2002 Jun 19;94(12):894-903. doi: 10.1093/jnci/94.12.894. J Natl Cancer Inst. 2002. PMID: 12072543

2

The Dutch FAMMM family material: clinical and genetic data.

Bergman W, Gruis NA, Frants RR. Bergman W, et al. Among authors: gruis na. Cytogenet Cell Genet. 1992;59(2-3):161-4. doi: 10.1159/000133232. Cytogenet Cell Genet. 1992. PMID: 1737487 No abstract available.

3

Locus for susceptibility to melanoma on chromosome 1p.

Gruis NA, Bergman W, Frants RR. Gruis NA, et al. N Engl J Med. 1990 Mar 22;322(12):853-4. doi: 10.1056/nejm199003223221217. N Engl J Med. 1990. PMID: 2308622 No abstract available.

4

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.

Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W, Frants RR. Gruis NA, et al. Melanoma Res. 1995 Jun;5(3):169-77. doi: 10.1097/00008390-199506000-00005. Melanoma Res. 1995. PMID: 7640518

5

Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9.

Bergman W, Gruis NA, Sandkuijl LA, Frants RR. Bergman W, et al. Among authors: gruis na. J Invest Dermatol. 1994 Nov;103(5 Suppl):122S-125S. doi: 10.1111/1523-1747.ep12399430. J Invest Dermatol. 1994. PMID: 7963673 Free article.

6

Familial melanoma and pancreatic cancer.

Bergman W, Gruis N. Bergman W, et al. Among authors: gruis n. N Engl J Med. 1996 Feb 15;334(7):471-2. N Engl J Med. 1996. PMID: 8552160 No abstract available.

7

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ. Liu L, et al. Among authors: gruis na. Genes Chromosomes Cancer. 1997 May;19(1):52-4. Genes Chromosomes Cancer. 1997. PMID: 9135995

8

Germline mutations of the CDKN2 gene in UK melanoma families.

Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Harland M, et al. Among authors: gruis n. Hum Mol Genet. 1997 Nov;6(12):2061-7. doi: 10.1093/hmg/6.12.2061. Hum Mol Genet. 1997. PMID: 9328469

9

Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.

Hille ET, van Duijn E, Gruis NA, Rosendaal FR, Bergman W, Vandenbroucke JP. Hille ET, et al. Among authors: gruis na. J Invest Dermatol. 1998 May;110(5):788-92. doi: 10.1046/j.1523-1747.1998.00185.x. J Invest Dermatol. 1998. PMID: 9579547 Free article.

10

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.

Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J, Hayward NK. Pollock PM, et al. Among authors: gruis n. Hum Mutat. 1998;11(6):424-31. doi: 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2. Hum Mutat. 1998. PMID: 9603434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page